TMO
Thermo Fisher Scientific Inc
NYSE: TMO · HEALTHCARE · DIAGNOSTICS & RESEARCH
$478.96
+2.72% today
Updated 2026-04-29
Market cap
$173.27B
P/E ratio
25.65
P/S ratio
3.83x
EPS (TTM)
$18.18
Dividend yield
0.37%
52W range
$384 – $643
Volume
2.0M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
4.7
Growth
C5.3
Quality
C+7.0
Profitability
B+4.0
Valuation
C3/9
Piotroski F-Score
Weak
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →202 stocks currently score above 75
Price targets
Analyst target
$620.54
+29.56%
12-Month target
$490.71
+2.45%
Intrinsic (DCF)
$407.91
Margin of safety
-17.42%
6 Strong Buy19 Buy3 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $816.00M — positive
Risks
- Piotroski 3/9 — weak financial health
- 17.42% above intrinsic value
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM | 2026 (E) |
|---|---|---|---|---|---|---|
| Revenue | $44.91B | $42.86B | $42.88B | $44.56B | $45.20B | $49.7B |
| Net income | $6.95B | $6.00B | $6.33B | $6.74B | $1.65B | — |
| EPS | — | — | — | — | $18.18 | $24.80 |
| Free cash flow | $6.91B | $6.93B | $7.27B | $6.29B | $816.00M | — |
| Profit margin | 15.47% | 13.99% | 14.77% | 15.12% | 15.10% | — |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-28 | WEISLER, DION J | Buy | 79 | — |
| 2026-03-28 | SPERLING, SCOTT M | Buy | 90 | — |
| 2026-03-28 | LYNCH, KAREN S | Buy | 66 | — |
Peer comparison
Smart narrative
Thermo Fisher Scientific Inc trades at $478.96. representing a P/E of 25.65x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 3/9 on the Piotroski F-Score. TTM revenue stands at $45.20B. with profit margins at 15.10%. Our DCF model estimates intrinsic value at $407.91.
Frequently asked questions
What is Thermo Fisher Scientific Inc's stock price?
Thermo Fisher Scientific Inc (TMO) trades at $478.96.
Is Thermo Fisher Scientific Inc overvalued?
Smart Value Score 62/100 (Grade C+, Hold). DCF value $407.91.
What is the price target of Thermo Fisher Scientific Inc (TMO)?
The analyst target price is $620.54, representing +29.6% upside from the current price of $478.96.
What is the intrinsic value of Thermo Fisher Scientific Inc (TMO)?
Based on our DCF model, intrinsic value is $407.91, a -17.4% margin of safety versus $478.96.
What is the future stock price of TMO by 2030?
Our research-backed model estimates Thermo Fisher Scientific Inc could reach $2,064.13 by 2030, based on analyst consensus, management guidance, and sector analysis.
What is Thermo Fisher Scientific Inc's revenue?
TTM revenue is $45.20B.
Piotroski F-Score?
3/9 — weak financial health.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio3.83x
ROE13.50%
Beta0.97
50D MA$497.05
200D MA$526.19
Shares out0.37B
Float0.37B
Short ratio—
Avg volume2.0M
Performance
1 week-0.73%
1 month-5.72%
3 months-19.42%
YTD-19.53%
1 year—
3 years—
5 years—